Sysmex Co. (OTCMKTS:SSMXY) Sees Large Decline in Short Interest

Sysmex Co. (OTCMKTS:SSMXY) was the recipient of a large decrease in short interest in the month of October. As of October 15th, there was short interest totalling 11,800 shares, a decrease of 56.6% from the September 30th total of 27,200 shares. Based on an average daily volume of 74,700 shares, the days-to-cover ratio is presently 0.2 days.

Sysmex Stock Performance

OTCMKTS SSMXY traded down $0.11 during trading on Friday, hitting $18.46. The company’s stock had a trading volume of 116,970 shares, compared to its average volume of 108,919. The firm has a market cap of $11.62 billion, a P/E ratio of 36.87 and a beta of 0.83. The company has a quick ratio of 2.40, a current ratio of 3.23 and a debt-to-equity ratio of 0.11. Sysmex has a 52 week low of $14.38 and a 52 week high of $29.78. The firm has a 50 day moving average price of $19.28 and a 200 day moving average price of $17.44.

Sysmex (OTCMKTS:SSMXY) last issued its earnings results on Tuesday, August 6th. The company reported $0.11 earnings per share (EPS) for the quarter. The firm had revenue of $718.13 million during the quarter. Equities research analysts forecast that Sysmex will post 0.65 earnings per share for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.